Dolores Schendel

Company: Medigene AG
Job title: CEO & CSO
Seminars:
Panel Discussion: Optimizing Development of Combination Approaches to Overcome the Solid Tumor Microenvironment 10:30 am
Exploring how to train T cells to overcome immune defence and survive in the low-nutrient, acidic and hypoxic tumour microenvironment Utilizing anti-PD1 antibody fragments secreted from T-cells after tumor interaction to overcome the local suppressive environment Profiling metabolic TME immuno-suppressive mechanisms through use of novel technology platformsRead more
day: Day Two
Helping TCR-Ts Meet the Challenges of the TME 10:00 am
Antigens/Epitopes contribute to success TCR sensitivity is of critical importance Enhanced TCR-Ts can overcome multiple hurdlesRead more
day: Day Two